Parnell Pharmaceuticals Holdings Ltd. (PARNF)

OTCMKTS: PARNF · Delayed Price · USD
0.0021
0.0001 (5.00%)
May 19, 2022 4:00 PM EDT - Market open
Market Cap38,106
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out18.15M
EPS (ttm)-0.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0000
Previous Close0.0020
Day's Range0.0000 - 0.0021
52-Week Range0.0001 - 0.3125
Beta-10.16
AnalystsBuy
Price Targetn/a
Earnings Daten/a

About PARNF

Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical p...

IndustryPharmaceuticals
IPO DateJun 18, 2014
CEORobert Joseph
Employees78
Stock ExchangeOTCMKTS
Ticker SymbolPARNF
Full Company Profile

News

There is no news available yet.